| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/11/2009 | US20090148523 System and process for providing at least one opening in dosage forms |
| 06/11/2009 | US20090148518 Pharmaceutical Formulations |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148483 Olfactory patch |
| 06/11/2009 | US20090148459 Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents |
| 06/11/2009 | US20090148438 Binding Moieties Based on Shark Ignar Domains |
| 06/11/2009 | US20090148422 Methods of proliferating stem cells |
| 06/11/2009 | CA2708044A1 Combination therapies using melengestrol acetate and zilpaterol or its salts |
| 06/11/2009 | CA2707718A1 Abcg2 inhibitor |
| 06/11/2009 | CA2707689A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | CA2706883A1 Methods of treating copd |
| 06/10/2009 | EP2067792A2 Inhibitory antibodies of HER3 activity |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066630A1 Piperidine derivatives |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP1837032A4 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
| 06/10/2009 | EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 06/10/2009 | EP1474385B1 Urea linker derivatives for use as ppar modulators |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN101450212A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496608C Medical aerosol formulations |
| 06/10/2009 | CN100496607C Combination of a NSAID and a PDE-4 inhibitor |
| 06/10/2009 | CN100496536C Alpha-glucosidase activity inhibitor |
| 06/10/2009 | CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 06/10/2009 | CN100496485C Antineoplastic combinations |
| 06/09/2009 | US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544653 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544509 Method for preparing stem cell preparations |
| 06/09/2009 | US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2401812C Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 06/09/2009 | CA2394232C Dual-release compositions of a cyclooxygenase-2-inhibitor |
| 06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
| 06/09/2009 | CA2337350C Polyhydroxyalkylpyrazine derivatives, their preparation, and pharmaceutical compositions containing them |
| 06/09/2009 | CA2326198C Cosolvent formulations |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009069828A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069704A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | WO2009069668A1 Agent for increasing the expression of malignant melanoma antigen, and use thereof |
| 06/04/2009 | WO2009069610A1 Fused indane compound |
| 06/04/2009 | WO2009069448A1 Adjuvant for japanese b encephalitis vaccine, and japanese b encephalitis vaccine |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009069280A1 Method for producing granulated matter |
| 06/04/2009 | WO2009068602A2 Oral care compositions comprising casein, ovalbumin, whey or soy protein |
| 06/04/2009 | WO2009045309A3 Use of v2 receptor antagonists in combination with vasopressinergic agonists |
| 06/04/2009 | US20090143487 Enhanced stability of proteins immobilized on nanoparticles |
| 06/04/2009 | US20090143467 Anticancer agents based on regulation of protein prenylation |
| 06/04/2009 | US20090143456 Polyamine Analogs as Modulators of Cell Migration and Cell Motility |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143430 Erythropoietin production accelerator |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143377 Methods and compositions for treating disorders |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143322 Cell transfecting formulations of small interfering rna related compositions and methods of making and use |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143298 Broad-Spectrum Delta-Endotoxins and Method and Kit for Detecting Same and for Detecting Polynucleotides Encoding Same |
| 06/04/2009 | US20090142834 Multipotent stem cells from peripheral tissues and uses thereof |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142402 Microparticles, microparticle dispersion and method and apparatus for producing the same |
| 06/04/2009 | US20090142399 Dispersant agent for sustained-release preparations |
| 06/04/2009 | US20090142391 Conjugated RNAi Therapeutics |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142358 Human antibodies specific to kdr and uses thereof |
| 06/04/2009 | US20090142340 Optimized Fc Variants and Methods for Their Generation |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |